Results 91 to 100 of about 526 (152)

Solriamfetol improves chronic sleep fragmentation-induced increases in sleep propensity and ameliorates explicit memory in male mice. [PDF]

Sleep, 2023
Puech C, Badran M, Barrow MB, Runion AR, Gozal D.   +4 more
europepmc   +1 more source

Approved and Pipeline Pharmacological Interventions for Eating Disorders (2010-2025): 15 Years of Progress (or Lack Thereof). [PDF]

CNS Drugs
Hirsch D, Reed J, Naqvi A, Ngor A, Dugan L, Costa K, Ganasi RS, Truman K, Danovitch I, IsHak WW, Hedrick R.   +10 more
europepmc   +1 more source

Comparaison du profil de sécurité du pitolisant et du solriamfétol : revue systématique et méta-analyse

Excessive daytime sleepiness is a symptom found in patients with narcolepsy or sleep apnoea-hypopnoea syndrome (SAHOS). The first-line drug treatments for excessive daytime sleepiness, pitolisant and solriamfetol, may have different safety profiles.
Toth, Rémi
core  

Correction to: SURWEY real-world study of solriamfetol: initiation, titration, safety, efficacy, and follow-up experience for patients with obstructive sleep apnea in Germany. [PDF]

Sleep Breath
Winter Y, Mayer G, Benes H, Burghaus L, Floam S, Parks GS, Kallweit U.   +6 more
europepmc   +1 more source

Sleep disorders in Parkinson's disease: evaluating pharmacological treatments through systematic review and meta-analysis. [PDF]

BMC Neurol
Li J, Zhou R, Deng J, Zhou H, Hu J, Wang X.   +5 more
europepmc   +1 more source

Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial

, 2021
Robert A. Hauser, Cynthia Comella, Helene Emsellem, Aleksandar Videnovic, Kris Liu, Amy W. Amara, Mildred D. Gottwald, Joshua R. Steinerman, Paula K. Schweitzer, Amanda L. Sterkel, Katie Zomorodi, Philip Jochelson   +11 more
core   +1 more source

A Comprehensive Review of Current and Emerging Treatments for Narcolepsy Type 1. [PDF]

J Clin Med
Xu Q, Chen Y, Wang T, Zhu Q, Xu J, Zhang L.   +5 more
europepmc   +1 more source

Therapeutic Use of Melatonin for Gastrointestinal Motility and Hypersomnolence in a Patient With Pineal Cyst Pathology. [PDF]

Am J Case Rep
Cross AR, Van Liew JR, Thakkar P, Brunia A.   +3 more
europepmc   +1 more source

Central nervous system stimulants in recreational and medical use. [PDF]

CNS Spectr
Dodd S, Ospina-Pinillos L, Markowitz JS.
europepmc   +1 more source

Navigating the intersection of mental health and kidney health: a systematic review of antidepressant safety in renal impairment. [PDF]

Discov Ment Health
Sarwar H, Zeshan M, Hussain N, Mogali E, Durrani R, Malasevskaia I.   +5 more
europepmc   +1 more source